TSPO–PET imaging using [(18)F]PBR06 is a potential translatable biomarker for treatment response in Huntington’s disease: preclinical evidence with the p75(NTR) ligand LM11A-31

por Simmons, Danielle A, James, Michelle L, Belichenko, Nadia P, Semaan, Sarah, Condon, Christina, Kuan, Jason, Shuhendler, Adam J, Miao, Zheng, Chin, Frederick T, Longo, Frank M
Publicado 2018

Neuroimaging, Urinary, and Plasma Biomarkers of Treatment Response in Huntington’s Disease: Preclinical Evidence with the p75(NTR) Ligand LM11A-31

por Simmons, Danielle A., Mills, Brian D., Butler III, Robert R., Kuan, Jason, McHugh, Tyne L. M., Akers, Carolyn, Zhou, James, Syriani, Wassim, Grouban, Maged, Zeineh, Michael, Longo, Frank M.
Publicado 2021